Cash from Operations (Quarterly) Chart

View Cash from Operations (Quarterly) for GENNQ.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Quarterly) Chart
Start Trial

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
September 30, 2021 -50.16M
June 30, 2021 22.78M
March 31, 2021 -48.94M
December 31, 2020 34.57M
September 30, 2020 -59.44M
June 30, 2020 325.35M
March 31, 2020 15.25M
December 31, 2019 -22.92M
September 30, 2019 -20.32M
June 30, 2019 23.94M
March 31, 2019 12.15M
December 31, 2018 4.518M
September 30, 2018 2.597M
June 30, 2018 17.56M
March 31, 2018 -6.087M
December 31, 2017 53.10M
September 30, 2017 -1.769M
June 30, 2017 24.50M
March 31, 2017 44.63M
December 31, 2016 33.06M
September 30, 2016 11.79M
June 30, 2016 -0.931M
March 31, 2016 24.45M
December 31, 2015 13.57M
September 30, 2015 2.78M
Date Value
June 30, 2015 -5.247M
March 31, 2015 -2.482M
December 31, 2014 22.29M
September 30, 2014 49.00M
June 30, 2014 23.54M
March 31, 2014 12.82M
December 31, 2013 11.09M
September 30, 2013 23.04M
June 30, 2013 9.308M
March 31, 2013 4.481M
December 31, 2012 11.74M
September 30, 2012 16.82M
June 30, 2012 15.14M
March 31, 2012 -1.022M
December 31, 2011 33.19M
September 30, 2011 20.96M
June 30, 2011 33.36M
March 31, 2011 11.88M
December 31, 2010 31.16M
September 30, 2010 -34.37M
June 30, 2010 20.37M
March 31, 2010 18.14M
December 31, 2009 29.49M
September 30, 2009 16.63M
June 30, 2009 20.81M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Regional Health Properties, Inc. 1.387M
Chemed Corp. 84.81M
The Ensign Group, Inc. 171.95M
National HealthCare Corp. 43.27M
Oncologix Tech, Inc. --